Lighthouse Pharma Presents Phase 2 SPRING Trial of LHP588 at CTAD
26 Nov 2025 //
PR NEWSWIRE
Phibro, Lighthouse Partner For Dog Periodontal Health Asset
09 Oct 2025 //
BUSINESSWIRE
Lighthouse Gets $49.2M NIA Grant for Alzheimer`s Study of LHP588
23 Aug 2025 //
PR NEWSWIRE
Lighthouse Announces FDA Approval To Proceed With Phase 2 Spring Trial Of LHP588
16 Nov 2023 //
PR NEWSWIRE
Lighthouse Pharmaceuticals Announces Presentation at the 2023 ASCP
24 May 2023 //
PR NEWSWIRE
Lighthouse Announces Progression of LHP588 Clinical Development Program
10 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support